Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Long-Acting Injection”

216 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 216 results

Early research (Phase 1)Looking for participantsNCT06724640
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV

Who this might be right for
HIV Infections
ViiV Healthcare 168
Large-scale testing (Phase 3)Study completedNCT00240708
What this trial is testing

The Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Pharmaceutical K.K. 205
Post-approval studies (Phase 4)Study completedNCT04940039
What this trial is testing

Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings

Who this might be right for
Schizophrenia
Janssen-Cilag International NV 93
Not applicableStudy completedNCT05152953
What this trial is testing

Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)

Who this might be right for
Hiv
University of California, San Francisco 63
Large-scale testing (Phase 3)Study completedNCT00236353
What this trial is testing

Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen, LP 86
Testing effectiveness (Phase 2)Active Not RecruitingNCT06411223
What this trial is testing

Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs

Who this might be right for
Hiv
Yale University 50
Post-approval studies (Phase 4)Study completedNCT03376763
What this trial is testing

MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics

Who this might be right for
SchizophreniaAntipsychoticsLong-Acting Injection+2 more
Korea Otsuka Pharmaceutical Co., Ltd. 201
Not applicableStudy completedNCT04973254
What this trial is testing

Improving Treatment and Retention Adherence in Nontraditional Settings

Who this might be right for
HIV Infections
Boston Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT07814651
What this trial is testing

A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With Acromegaly

Who this might be right for
Acromegaly
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 78
Post-approval studies (Phase 4)Study completedNCT00246259
What this trial is testing

A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
Janssen-Ortho Inc., Canada 77
Not applicableLooking for participantsNCT07221747
What this trial is testing

PathToScale: The PERSIST Trial

Who this might be right for
Oral Pre-exposure Prophylaxis (PrEP)Long-acting Injectable Cabotegravir for PrEP
Georgetown University 9,900
Not applicableNot Yet RecruitingNCT06403865
What this trial is testing

Patient-Reported Outcomes in Real-life of Cabotegravir and Rilpivirine

Who this might be right for
Quality of Life
University Paris 7 - Denis Diderot 280
Testing effectiveness (Phase 2)Study completedNCT02165202
What this trial is testing

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis

Who this might be right for
Human Immunodeficiency Virus (HIV)
PATH 136
Early research (Phase 1)Looking for participantsNCT07484204
What this trial is testing

Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Anxo Pharmaceutical Co., Ltd. 48
Post-approval studies (Phase 4)Study completedNCT00216632
What this trial is testing

Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen Pharmaceutica N.V., Belgium 99
Not applicableStudy completedNCT05799339
What this trial is testing

Optimizing CAB-LA as PrEP for Women Who Inject Drugs

Who this might be right for
HIV InfectionsOpioid UseTrauma, Psychological
Alexis Roth 144
Not applicableStudy completedNCT05473741
What this trial is testing

Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

Who this might be right for
SchizophreniaSchizophrenia Relapse
Centre for Addiction and Mental Health 51
Early research (Phase 1)Study completedNCT04828694
What this trial is testing

Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections

Who this might be right for
Opioid-use Disorder
BioCorRx Inc 24
Not applicableLooking for participantsNCT06501781
What this trial is testing

Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)

Who this might be right for
HIV InfectionsSubstance Use
University of Maryland, Baltimore 186
Large-scale testing (Phase 3)Study completedNCT00843687
What this trial is testing

A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188
Next Page